¥480.00
2.83%
Tokyo, Nov 20, 03:17 pm JST. Closed.
ISIN
JP3701000006
Symbol
4552

Jcr Pharmaceuticals Co.,ltd. Stock price

¥480.00
-42.00 8.05% 1M
-13.00 2.64% 6M
-232.00 32.58% YTD
-155.00 24.41% 1Y
-790.00 62.20% 3Y
-2,178.61 81.95% 5Y
-232.76 32.66% 10Y
+286.70 148.32% 20Y
Tokyo, Closing price Fri, Nov 20 2026
-14.00 2.83%
ISIN
JP3701000006
Symbol
4552
Industry

AI Insights on Jcr Pharmaceuticals Co.,ltd. Insights AI Insights on Jcr Pharmaceuticals Co.,ltd.

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?

Is Jcr Pharmaceuticals Co.,ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,086 stocks worldwide.

Key metrics

Basic
Market capitalization
¥61.1b
Enterprise Value
¥114.4b
Net debt
¥53.2b
Cash
¥10.4b
Shares outstanding
122.3m
Valuation
P/E
negative
P/S | estimate
1.6 | 1.4
EV/Sales | estimate
2.9 | 2.6
EV/FCF | ex SBC
negative | -
P/B
1.5
Dividends
DPS
¥20.00
Yield 1Y | 5Y
4.2% | 1.9%
Growth 1Y | 5Y
0.0% | 0.0%
Payout 1Y | 3Y
112.0% | 257.0%
Increased
0 Years
Financials
Revenue | estimate
¥38.9b | ¥44.5b
EBITDA
¥-1.3b
EBIT
¥-3.5b
Net Income
¥-3.4b
Free Cash Flow | ex SBC
¥-24.7b | -
Growth
Revenue | estimate
3.1% | 10.3%
EBITDA
62.8%
EBIT
5.6%
Net Income
-44.1%
Free Cash Flow
-150.8%
Margin
Gross
70.3%
EBITDA
-3.4%
EBIT
-9.0%
Net
-8.7%
Free Cash Flow | ex SBC
-63.5% | -
Financial Health
Equity Ratio
43.0%
Return on Equity
4.6%
ROCE
-6.4%
ROIC
-3.9%
Debt/Equity
1.6
More
EPS
¥-27.8
FCF per Share
¥-202.3
Short interest
-
Employees
987
Rev per Employee
¥40.9m

Jcr Pharmaceuticals Co.,ltd. Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Jcr Pharmaceuticals Co.,ltd. forecast:

5x Buy
45%
6x Hold
55%

Analyst Opinions

11 Analysts have issued a Jcr Pharmaceuticals Co.,ltd. forecast:

Buy
45%
Hold
55%

Financial data from Jcr Pharmaceuticals Co.,ltd.

Sep '26
+/-
%
38,931 38,931
3% 3%
100%
- Direct Costs 11,563 11,563
2% 2%
30%
27,368 27,368
3% 3%
70%
- Selling and Administrative Expenses 32,696 32,696
9% 9%
84%
- Research and Development Expense - -
-
-
-1,315 -1,315
63% 63%
-3%
- Depreciation and Amortization 2,179 2,179
1,182% 1,182%
6%
EBIT (Operating Income) EBIT -3,494 -3,494
6% 6%
-9%
Net Profit -3,399 -3,399
44% 44%
-9%

In millions JPY.

Don't miss a Thing! We will send you all news about Jcr Pharmaceuticals Co.,ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

JCR Pharmaceuticals Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Ashiya-Shi, Hyogo-Ken and currently employs 987 full-time employees. The company manufactures, purchases, and sells prescription drugs, regenerative medicine products, and pharmaceutical raw materials. Through its subsidiaries, it is also engaged in purchasing business, procurement and sales of medical and research equipment, facility management, market research, management and supervision of outsourced clinical trial operations, management of intellectual property and licensing, clinical operations, regulatory affairs, and development in Brazil and Europe, and distribution management of pharmaceuticals and their raw materials.

Head office Japan
CEO Mr. Ashida
Employees 987
Website www.jcrpharm.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today